109 related articles for article (PubMed ID: 16107724)
1. A dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic background.
Cowley DO; Muse GW; Van Dyke T
Mol Cell Biol; 2005 Sep; 25(17):7796-802. PubMed ID: 16107724
[TBL] [Abstract][Full Text] [Related]
2. Impaired phosphorylation and mis-localization of Bub1 and BubR1 are responsible for the defective mitotic checkpoint function in Brca2-mutant thymic lymphomas.
Lee H
Exp Mol Med; 2003 Oct; 35(5):448-53. PubMed ID: 14646599
[TBL] [Abstract][Full Text] [Related]
3. Bub1 up-regulation and hyperphosphorylation promote malignant transformation in SV40 tag-induced transgenic mouse models.
Guo C; Wu G; Chin JL; Bauman G; Moussa M; Wang F; Greenberg NM; Taylor SS; Xuan JW
Mol Cancer Res; 2006 Dec; 4(12):957-69. PubMed ID: 17189386
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.
Grabsch H; Takeno S; Parsons WJ; Pomjanski N; Boecking A; Gabbert HE; Mueller W
J Pathol; 2003 May; 200(1):16-22. PubMed ID: 12692836
[TBL] [Abstract][Full Text] [Related]
5. Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2.
Lee H; Trainer AH; Friedman LS; Thistlethwaite FC; Evans MJ; Ponder BA; Venkitaraman AR
Mol Cell; 1999 Jul; 4(1):1-10. PubMed ID: 10445022
[TBL] [Abstract][Full Text] [Related]
6. Genomic instability at the BUB1 locus in colorectal cancer, but not in non-small cell lung cancer.
Jaffrey RG; Pritchard SC; Clark C; Murray GI; Cassidy J; Kerr KM; Nicolson MC; McLeod HL
Cancer Res; 2000 Aug; 60(16):4349-52. PubMed ID: 10969775
[TBL] [Abstract][Full Text] [Related]
7. Minireview: branded from the start-distinct oncogenic initiating events may determine tumor fate in the thyroid.
Fagin JA
Mol Endocrinol; 2002 May; 16(5):903-11. PubMed ID: 11981026
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1.
Ouyang B; Knauf JA; Ain K; Nacev B; Fagin JA
Clin Endocrinol (Oxf); 2002 Mar; 56(3):341-50. PubMed ID: 11940046
[TBL] [Abstract][Full Text] [Related]
9. Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1.
Cotsiki M; Lock RL; Cheng Y; Williams GL; Zhao J; Perera D; Freire R; Entwistle A; Golemis EA; Roberts TM; Jat PS; Gjoerup OV
Proc Natl Acad Sci U S A; 2004 Jan; 101(4):947-52. PubMed ID: 14732683
[TBL] [Abstract][Full Text] [Related]
10. Bub1 kinase activity drives error correction and mitotic checkpoint control but not tumor suppression.
Ricke RM; Jeganathan KB; Malureanu L; Harrison AM; van Deursen JM
J Cell Biol; 2012 Dec; 199(6):931-49. PubMed ID: 23209306
[TBL] [Abstract][Full Text] [Related]
11. Human Bub1: a putative spindle checkpoint kinase closely linked to cell proliferation.
Ouyang B; Lan Z; Meadows J; Pan H; Fukasawa K; Li W; Dai W
Cell Growth Differ; 1998 Oct; 9(10):877-85. PubMed ID: 9790499
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
[TBL] [Abstract][Full Text] [Related]
13. Surveillance mechanism linking Bub1 loss to the p53 pathway.
Gjoerup OV; Wu J; Chandler-Militello D; Williams GL; Zhao J; Schaffhausen B; Jat PS; Roberts TM
Proc Natl Acad Sci U S A; 2007 May; 104(20):8334-9. PubMed ID: 17488820
[TBL] [Abstract][Full Text] [Related]
14. hBUB1 defects in leukemia and lymphoma cells.
Ru HY; Chen RL; Lu WC; Chen JH
Oncogene; 2002 Jul; 21(30):4673-9. PubMed ID: 12096343
[TBL] [Abstract][Full Text] [Related]
15. Spindle checkpoint protein Bub1 corrects mitotic aberrancy induced by human T-cell leukemia virus type I Tax.
Sasaki M; Sugimoto K; Tamayose K; Ando M; Tanaka Y; Oshimi K
Oncogene; 2006 Jun; 25(26):3621-7. PubMed ID: 16449967
[TBL] [Abstract][Full Text] [Related]
16. Expression of BUB1 protein in gastric cancer correlates with the histological subtype, but not with DNA ploidy or microsatellite instability.
Grabsch HI; Askham JM; Morrison EE; Pomjanski N; Lickvers K; Parsons WJ; Boecking A; Gabbert HE; Mueller W
J Pathol; 2004 Feb; 202(2):208-14. PubMed ID: 14743503
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression.
Doak SH; Jenkins GJ; Parry EM; Griffiths AP; Baxter JN; Parry JM
Mutat Res; 2004 Mar; 547(1-2):133-44. PubMed ID: 15013707
[TBL] [Abstract][Full Text] [Related]
18. p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation.
Ha GH; Baek KH; Kim HS; Jeong SJ; Kim CM; McKeon F; Lee CW
Cancer Res; 2007 Aug; 67(15):7155-64. PubMed ID: 17671183
[TBL] [Abstract][Full Text] [Related]
19. A dual role for Bub1 in the spindle checkpoint and chromosome congression.
Meraldi P; Sorger PK
EMBO J; 2005 Apr; 24(8):1621-33. PubMed ID: 15933723
[TBL] [Abstract][Full Text] [Related]
20. A double missense variation of the BUB1 gene and a defective mitotic spindle checkpoint in the pancreatic cancer cell line Hs766T.
Hempen PM; Kurpad H; Calhoun ES; Abraham S; Kern SE
Hum Mutat; 2003 Apr; 21(4):445. PubMed ID: 12655561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
